Mohammad Masjedizadeh
Chief Tech/Sci/R&D Officer en PROTAGONIST THERAPEUTICS, INC. .
Perfil
Mohammad Masjedizadeh is currently the Chief Technical Officer & Executive VP at Protagonist Therapeutics, Inc. Prior to this, he was the Senior Director-Technical Operations at Principia Biopharma, Inc. from 2012 to 2017.
He also worked at Roche Pharmaceuticals, Inc. and Roche Palo Alto LLC as the Director-Drug Substance & Supply from 1991 to 2012.
Dr. Masjedizadeh holds a doctorate degree from the University of California, Santa Barbara.
Cargos activos de Mohammad Masjedizadeh
| Empresas | Cargo | Inicio |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/06/2021 |
Antiguos cargos conocidos de Mohammad Masjedizadeh.
| Empresas | Cargo | Fin |
|---|---|---|
| PRINCIPIA BIOPHARMA INC. | Chief Tech/Sci/R&D Officer | 01/01/2017 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01/01/2012 |
Roche Palo Alto LLC
 Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | 01/01/2012 |
Formación de Mohammad Masjedizadeh.
| University of California, Santa Barbara | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Mohammad Masjedizadeh
